Insider Transactions in Q1 2024 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,000
-73.46%
|
$261,000
$29.5 P/Share
|
|
Mar 28
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+42.35%
|
$18,000
$2.14 P/Share
|
|
Mar 27
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
11,068
-89.55%
|
$298,836
$27.97 P/Share
|
|
Mar 27
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
11,068
+47.24%
|
$110,680
$10.61 P/Share
|
|
Mar 25
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,432
-72.67%
|
$96,096
$28.01 P/Share
|
|
Mar 25
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+42.08%
|
$34,320
$10.61 P/Share
|
|
Mar 19
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,300
-73.92%
|
$137,800
$26.07 P/Share
|
|
Mar 19
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+50.0%
|
$74,200
$14.59 P/Share
|
|
Mar 18
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
35,057
-80.52%
|
$911,482
$26.11 P/Share
|
|
Mar 18
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
35,057
+38.5%
|
$210,342
$6.38 P/Share
|
|
Mar 18
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-39.09%
|
$182,000
$26.11 P/Share
|
|
Mar 18
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+29.1%
|
$7,000
$1.94 P/Share
|
|
Mar 13
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
2,016
-50.7%
|
$50,400
$25.02 P/Share
|
|
Mar 13
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
2,016
+33.64%
|
$4,032
$2.14 P/Share
|
|
Mar 12
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
2,051
-51.13%
|
$51,275
$25.05 P/Share
|
|
Mar 12
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
2,051
+33.83%
|
$4,102
$2.14 P/Share
|
|
Mar 11
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
3,433
-31.99%
|
$85,825
$25.77 P/Share
|
|
Mar 11
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
3,433
+38.9%
|
$6,866
$2.14 P/Share
|
|
Mar 08
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
114
-5.5%
|
$2,850
$25.0 P/Share
|
|
Mar 08
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+5.21%
|
$228
$2.14 P/Share
|
|
Mar 07
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,975
-73.41%
|
$215,400
$24.5 P/Share
|
|
Mar 07
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,975
+42.33%
|
$17,950
$2.14 P/Share
|
|
Mar 07
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
22,386
-91.95%
|
$559,650
$25.0 P/Share
|
|
Mar 07
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
22,386
+47.9%
|
$44,772
$2.14 P/Share
|
|
Feb 23
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
511
-13.58%
|
$9,709
$19.5 P/Share
|
|
Feb 23
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
511
+11.96%
|
$511
$1.74 P/Share
|
|
Feb 20
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,489
-30.04%
|
$69,780
$20.35 P/Share
|
|
Feb 20
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,489
+34.11%
|
$3,489
$1.74 P/Share
|
|
Feb 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-74.09%
|
$78,200
$17.45 P/Share
|
|
Feb 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+32.88%
|
$4,600
$1.94 P/Share
|
|
Jan 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-55.16%
|
$76,000
$19.5 P/Share
|
|
Jan 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+35.55%
|
$4,000
$1.74 P/Share
|
|
Jan 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-47.42%
|
$87,400
$19.12 P/Share
|
|
Jan 05
2024
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+32.88%
|
$4,600
$1.94 P/Share
|